BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10972854)

  • 21. Analysis of immune responses against T- and B-cell epitopes from Plasmodium falciparum liver-stage antigen 1 in rodent malaria models and malaria-exposed human subjects in India.
    Joshi SK; Bharadwaj A; Chatterjee S; Chauhan VS
    Infect Immun; 2000 Jan; 68(1):141-50. PubMed ID: 10603380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for multiple B- and T-cell epitopes in Plasmodium falciparum liver-stage antigen 3.
    Toure-Balde A; Perlaza BL; Sauzet JP; Ndiaye M; Aribot G; Tall A; Sokhna C; Rogier C; Corradin G; Roussilhon C; Druilhe P
    Infect Immun; 2009 Mar; 77(3):1189-96. PubMed ID: 19139199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
    Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
    Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational characterization of Plasmodium falciparum proteomic data for screening of potential vaccine candidates.
    Singh SP; Khan F; Mishra BN
    Hum Immunol; 2010 Feb; 71(2):136-43. PubMed ID: 19945493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmodium falciparum: genetic polymorphism in apical membrane antigen-1 gene from Indian isolates.
    Rajesh V; Singamsetti VK; Vidya S; Gowrishankar M; Elamaran M; Tripathi J; Radhika NB; Kochar D; Ranjan A; Roy SK; Das A
    Exp Parasitol; 2008 May; 119(1):144-51. PubMed ID: 18343371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Review of Human
    Heide J; Vaughan KC; Sette A; Jacobs T; Schulze Zur Wiesch J
    Front Immunol; 2019; 10():397. PubMed ID: 30949162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-DQB1*0501-restricted Th1 type immune responses to Plasmodium falciparum liver stage antigen 1 protect against malaria anemia and reinfections.
    May J; Lell B; Luty AJ; Meyer CG; Kremsner PG
    J Infect Dis; 2001 Jan; 183(1):168-72. PubMed ID: 11076705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-binding between Plasmodium falciparum CTL epitopes and HLA class I molecules.
    Tang Y; Lin Y; Mao Y; Dong M; Wang H
    Immunol Invest; 2003 Feb; 32(1-2):31-41. PubMed ID: 12722940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP).
    Sedegah M; Kim Y; Ganeshan H; Huang J; Belmonte M; Abot E; Banania JG; Farooq F; McGrath S; Peters B; Sette A; Soisson L; Diggs C; Doolan DL; Tamminga C; Villasante E; Hollingdale MR; Richie TL
    Malar J; 2013 Jun; 12():185. PubMed ID: 23738590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amino acid dimorphism and parasite immune evasion: cellular immune responses to a promiscuous epitope of Plasmodium falciparum merozoite surface protein 1 displaying dimorphic amino acid polymorphism are highly constrained.
    Daubenberger CA; Nickel B; Ciatto C; Grütter MG; Pöltl-Frank F; Rossi L; Siegler U; Robinson J; Kashala O; Patarroyo ME; Pluschke G
    Eur J Immunol; 2002 Dec; 32(12):3667-77. PubMed ID: 12516559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of HLA-A24 restricted pre-erythrocytic stage specific T-cell epitopes using Plasmodium falciparum synthetic peptides: a preliminary study.
    Tippawangkosol P; Duangchanda T; Ubalee R; Ruengweerayut R; Hirayama K; Na-Bangchang K
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):10-7. PubMed ID: 19323028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic diversity of vaccine candidate antigens in Plasmodium falciparum isolates from the Amazon basin of Peru.
    Chenet SM; Branch OH; Escalante AA; Lucas CM; Bacon DJ
    Malar J; 2008 May; 7():93. PubMed ID: 18505558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of recombinant adenovirus serotype 35 priming versus boosting of a Plasmodium falciparum protein: characterization of T- and B-cell responses to liver-stage antigen 1.
    Rodríguez A; Goudsmit J; Companjen A; Mintardjo R; Gillissen G; Tax D; Sijtsma J; Weverling GJ; Holterman L; Lanar DE; Havenga MJ; Radosevic K
    Infect Immun; 2008 Apr; 76(4):1709-18. PubMed ID: 18212075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epitope analysis of human T-cell response to MSP-1 of Plasmodium falciparum in malaria-nonexposed individuals.
    Ohta N; Iwaki K; Itoh M; Fu J; Nakashima S; Hato M; Tolle R; Bujard H; Saitoh A; Tanabe K
    Int Arch Allergy Immunol; 1997 Sep; 114(1):15-22. PubMed ID: 9303326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of B cell and T cell epitopes of DBLalpha domain in Plasmodium falciparum malaria vaccine candidate var gene.
    Ozarkar AD; Prakash D; Deobagkar DN; Deobagkar DD
    Protein Pept Lett; 2007; 14(6):528-30. PubMed ID: 17627591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic T cell reactivity and HLA-B35 binding of the variant Plasmodium falciparum circumsporozoite protein CD8+ CTL epitope in naturally exposed Kenyan adults.
    Udhayakumar V; Ongecha JM; Shi YP; Aidoo M; Orago AS; Oloo AJ; Hawley WA; Nahlen BL; Hoffman SL; Weiss WR; Lal AA
    Eur J Immunol; 1997 Aug; 27(8):1952-7. PubMed ID: 9295031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malaria vaccine based on self-assembling protein nanoparticles.
    Burkhard P; Lanar DE
    Expert Rev Vaccines; 2015; 14(12):1525-7. PubMed ID: 26468608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited genetic diversity in the global Plasmodium vivax Cell traversal protein of Ookinetes and Sporozoites (CelTOS) sequences; implications for PvCelTOS-based vaccine development.
    Mehrizi AA; Torabi F; Zakeri S; Djadid ND
    Infect Genet Evol; 2017 Sep; 53():239-247. PubMed ID: 28600217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploitation of reverse vaccinology and immunoinformatics as promising platform for genome-wide screening of new effective vaccine candidates against Plasmodium falciparum.
    Pritam M; Singh G; Swaroop S; Singh AK; Singh SP
    BMC Bioinformatics; 2019 Feb; 19(Suppl 13):468. PubMed ID: 30717656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
    Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
    J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.